Weeks 2-4: Early Immune Marker Shifts What is happening: Dendritic cell maturation translates into enhanced antigen presentation to T-cells. CD4+ and CD8+ T-cell activation increases. NK cell activity begins to improve.…
Affiliate disclosure: vendor links in this article are affiliate links — The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you. Where These Numbers Come From Thymosin alpha-1 ha…
Thymosin alpha-1 is an immune-modulating peptide — its effects happen inside the immune system, not on a scale or in a mirror. Without bloodwork, you are guessing whether it is working. Research-context information only…
Thymosin alpha-1 (Ta1) is a 28-amino acid peptide originally isolated from thymic tissue — the compound responsible for restoring immune function in thymectomized mice. Its synthetic form, thymalfasin, is approved in ov…
IGF-1 Elevation as a Pharmacologic Signal Tesamorelin raises IGF-1 by stimulating endogenous GH release. The Phase 3 trial reported mean IGF-1 elevation of approximately 80% from baseline at 26 weeks (PMID 18057338). FD…
Months 2-3: Measurable Body Composition Changes This is where data starts showing up in measurements, not just blood work. The clinical trials begin detecting meaningful differences from placebo during this window. What…
Tesamorelin ships as a lyophilized (freeze-dried) powder that is reconstituted with bacteriostatic water before use. Trial protocols and community sources describe a standard reconstitution process, with one simplifying…
Affiliate disclosure: vendor links in this article are affiliate links — The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you. Ready to buy? Compare the top vendors on our best…
Tesamorelin is a synthetic GHRH analog that stimulates endogenous growth hormone production. It is the only FDA-approved treatment for reducing visceral fat in HIV-associated lipodystrophy, with Phase III trial data sho…
Tesamorelin is one of the few peptides with FDA approval and Phase III clinical trial data behind it. Originally approved for HIV-associated lipodystrophy, its benefits extend well beyond that population — spanning visc…
The Cancer-Concern Context TB-4's pro-angiogenic and pro-migratory mechanism — the same property that enables wound healing — has prompted theoretical concern in users with active malignancy or strong personal cancer hi…
TB-500 is a synthetic 17-amino-acid fragment of Thymosin Beta-4, containing the active actin-binding domain responsible for cell migration and tissue repair. It's a cornerstone of healing peptide protocols, especially w…
TB-500 is a synthetic fragment of thymosin beta-4, a 43-amino-acid peptide that the body releases naturally after injury. It contains the active region (the Ac-SDKP actin-binding domain) responsible for cell migration, …
Affiliate disclosure: vendor links in this article are affiliate links — The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you. Where These Numbers Come From Community doses are…
On April 12, 2026, the journal Sports Medicine published a peer-reviewed review by Christopher L. Mendias and colleagues titled "Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injur…
The "exercise mimetic" label gets stuck on multiple compounds, but they are not interchangeable. SLU-PP-332 and MOTS-c both produce a transcriptional and metabolic phenotype that overlaps with what endurance training pr…
Self-Reported Community Adverse Events for Adult Use Note on labeling: the events below come from r/peptides, r/PeptideTherapy, and community forums for adult subcutaneous sermorelin use, typically at doses substantiall…
Sermorelin is a synthetic version of the first 29 amino acids of human growth hormone-releasing hormone (GHRH). It was formerly FDA-approved for GH deficiency diagnosis, giving it a unique history of clinical safety dat…
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) — specifically the first 29 amino acids of the 44-amino-acid native hormone. It binds the GHRH receptor on pituitary somatotrophs, triggering n…
Self-Reported Community Adverse Events Note on labeling: the events below come from r/nootropics, r/peptides, and community forums for intranasal research-peptide semax use, typically at lower doses than Russian stroke …